Vital Signs Market Research Reports

Subscribe to RSS Feed
  1. 26 Jan 2011  |  North America  |  Market Research

    Vital Signs - Taking Stock of the Next Generation of Medical Implant Technologies

     

    This issue of Vital Signs, released on January 26, 2011, provides a strategic overview of the next generation of medical implant technologies. Additionally, a company spotlight is provided for Ardian, Inc., a novel catheter-based treatment company for diseases related to sympathetic hyperactivity, including hypertension, chronic kidney disease, ins...

    $1,500.00
  2. 17 Jan 2011  |  North America  |  Market Research

    Vital Signs - CETP Inhibitors  Promising Treatments in Development for Dyslipidemia

     

    This issue of Vital Signs, released on January 17, 2011, provides a strategic overview of CETP inhibitor treatments in development for dyslipidemia. Additionally, a company spotlight is provided for DARA BioSciences, a development stage biopharmaceutical company. Reimbursement and regulatory news from the FDA is also provided for the week of Decemb...

    $1,500.00
  3. This issue of Vital Signs, released on December 20, 2010, provides a strategic overview of the integration and changes to the cardiopulmonary resuscitation sequence. Additionally, a company spotlight is provided for Echo Therapeutics, a transdermal medical device company with deep expertise in advanced skin permeation technology. Reimbursement and ...

    $1,500.00
  4. 06 Dec 2010  |  North America  |  Market Research

    Vital Signs - NGS Dx: The Future of Sequencing in the Clinical Laboratory

     

    This issue of Vital Signs, released on December 6, 2010, provides a strategic overview of key issues and trends relating to next-generation sequencing. Additionally, a company spotlight is provided for GenturaDx, a company who has an exclusive license to more than 100 patents for assays, which should allow the company to develop an incredibly broad...

    $1,500.00
  5. This issue of Vital Signs, released on November 15, 2010, provides a strategic overview of key issues and trends relating to the lack of standardized acute care world wide. Additionally, a company spotlight is provided for Insera Therapeutics, LLC, an innovative medical device developer addressing solutions for complex neurovascular diseases. Reimb...

    $1,500.00
  6. 08 Nov 2010  |  North America  |  Market Research

    Vital Signs - Long-Term Weight Loss Treatments

     

    This issue of Vital Signs, released on November 8, 2010, provides a strategic overview of key issues and trends relating to prescription medications for long-term weight loss. Additionally, a company spotlight is provided for Vitae Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on building a portfolio of novel, small mole...

    $1,500.00
  7. 01 Nov 2010  |  North America  |  Market Research

    Vital Signs - Contract Research Outsourcing: Market Trends  2010 & Beyond

     

    This issue of Vital Signs, released on November 1, 2010, provides a strategic overview of key issues and trends relating to contract research outsourcing. Additionally, a company spotlight is provided for Accelovance, a vaccine-focused CRO that has established itself in delivering an innovative and proven approach to accelerated clinical developmen...

    $1,500.00
  8. This issue of Vital Signs, released on October 25, 2010, provides a strategic overview of key issues and trends relating to strategic product life cycle management in medical technology companies. Additionally, a company spotlight is provided for Celestica, a leading global strategic service provider to the medical devices industry. Reimbursement a...

    $1,500.00
  9. 18 Oct 2010  |  North America  |  Market Research

    Vital Signs - Biopharmaceutical Drug Delivery: Going Beyond Injection

     

    This issue of Vital Signs, released on October 18, 2010, provides a strategic overview of key issues and trends relating to advances in biopharmaceutical drug delivery. Additionally, a company spotlight is provided for QRxPharma Ltd., a clinical stage specialty pharmaceutical company focused on the development and commercialization of new therapies...

    $1,500.00
  10. 04 Oct 2010  |  North America  |  Market Research

    Vital Signs - Refurbished Medical Equipment: Strong Growth Prospects in Healthcare Market

     

    This issue of Vital Signs, released on October 4, 2010, provides a strategic overview of key issues and trends relating to refurbished medical equipment. Additionally, a company spotlight is provided for Soma Technology, Inc., who provides high quality new and refurbished medical equipment to healthcare facilities worldwide at affordable costs. Rei...

    $1,500.00